Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1
Mark Andrew White, Natalia Mast, Ingemar Bjorkhem, Eric F Johnson, C David Stout, Irina A Pikuleva, Mark Andrew White, Natalia Mast, Ingemar Bjorkhem, Eric F Johnson, C David Stout, Irina A Pikuleva
Abstract
Human cytochrome P450 46A1 (CYP46A1) is one of the key enzymes in cholesterol homeostasis in the brain. The crystallization and heavy-atom structure solution of an active truncated CYP46A1 in complex with the high-affinity substrate analogue cholesterol-3-sulfate (CH-3S) is reported. The 2.6 angstroms structure of CYP46A1-CH-3S was solved using both anion and cation heavy-atom salts. In addition to the native anomalous signal from the haem iron, an NaI anion halide salt derivative and a complementary CsCl alkali-metal cation salt derivative were used. The general implications of the use of halide and alkali-metal quick soaks are discussed. The importance of using isoionic strength buffers, the titration of heavy-atom salts into different ionic species and the role of concentration are considered. It was observed that cation/anion-binding sites will occasionally overlap, which could negatively impact upon mixed RbBr soaks used for multiple anomalous scatterer MAD (MMAD). The use of complementary cation and anion heavy-atom salt derivatives is a convenient and powerful tool for MIR(AS) structure solution.
Figures
References
- Afonine, P. V., Grosse-Kunstleve, R. W. & Adams, P. D. (2005). Acta Cryst. D61, 850–855.
- Bogdanovic, N., Bretillon, L., Lund, E. G., Diczfalusy, U., Lannfelt, L., Winblad, B., Russell, D. W. & Bjorkhem, I. (2001). Neurosci. Lett.314, 45–48.
- Bretillon, L., Diczfalusy, U., Bjorkhem, I., Maire, M. A., Martine, L., Joffre, C., Acar, N., Bron, A. & Creuzot-Garcher, C. (2007). Curr. Eye Res.32, 361–366.
- Brown, J. III, Theisler, C., Silberman, S., Magnuson, D., Gottardi-Littell, N., Lee, J. M., Yager, D., Crowley, J., Sambamurti, K., Rahman, M. M., Reiss, A. B., Eckman, C. B. & Wolozin, B. (2004). J. Biol. Chem.279, 34674–34681.
- Buerger, M. J. (1959). Vector Space and its Application in Crystal Structure Investigation. New York: Wiley.
- Chawla, A., Repa, J. J., Evans, R. M. & Mangelsdorf, D. J. (2001). Science, 294, 1866–1870.
- Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J. & Russell, D. W. (2007). Cell Metab.5, 73–79.
- Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763.
- Dauter, M. & Dauter, Z. (2006). Methods Mol. Biol.364, 149–158.
- Dauter, Z. & Dauter, M. (2001). Structure, 9, R21–R26.
- Dauter, Z., Dauter, M. & Rajashankar, K. R. (2000). Acta Cryst. D56, 232–237.
- DeLano, W. L. (2003). The PyMOL Molecular Graphics System. .
- Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.
- Evans, G. & Bricogne, G. (2002). Acta Cryst. D58, 976–991.
- Garman, E. & Murray, J. W. (2003). Acta Cryst. D59, 1903–1913.
- Gewirth, D. (2003). The HKL Manual, v.1.0. Charlottesville, USA: HKL Research.
- Gopal, K., McKee, E., Romo, T., Pai, R., Smith, J., Sacchettini, J. & Ioerger, T. (2007). Bioinformatics, 23, 375–377.
- Graham, S. E. & Peterson, J. A. (1999). Arch. Biochem. Biophys.369, 24–29.
- Guengerich, F. P. (2001). Chem. Res. Toxicol.14, 611–650.
- Guengerich, F. P. (2005). Cytochrome P450, edited by P. R. Ortiz de Montellano, pp. 377–530. Dordrecht: Kluwer Academic Publishers.
- Helisalmi, S., Vepsalainen, S., Koivisto, A. M., Mannermaa, A., Iivonen, S., Hiltunen, M., Kiviniemi, V. & Soininen, H. (2006). J. Neurol. Neurosurg. Psychiatr.77, 421–422.
- Iwamori, M., Moser, H. W. & Kishimoto, Y. (1976). Biochim. Biophys. Acta, 441, 268–279.
- Johnson, E. F. & Stout, C. D. (2005). Biochem. Biophys. Res. Commun.338, 331–336.
- Jonstrup, A. T., Andersen, K. R., Van, L. B. & Brodersen, D. E. (2007). Nucleic Acids Res.35, 3153–3164.
- Korolev, S., Dementieva, I., Sanishvili, R., Minor, W., Otwinowski, Z. & Joachimiak, A. (2001). Acta Cryst. D57, 1008–1012.
- Kotti, T. J., Ramirez, D. M., Pfeiffer, B. E., Huber, K. M. & Russell, D. W. (2006). Proc. Natl Acad. Sci. USA, 103, 3869–3874.
- Li, H. & Poulos, T. L. (2004). Curr. Top. Med. Chem.4, 1789–1802.
- Li, Y., Chu, L. W., Chen, Y. Q., Cheung, B. M., Leung, R. Y., Yik, P. Y., Ng, K. M., Mak, W., Jin, D. Y., St George-Hyslop, P. & Song, Y. Q. (2006). Dement. Geriatr. Cogn. Disord.22, 399–404.
- Liu, S., Sjovall, J. & Griffiths, W. J. (2003). Anal. Chem.75, 5835–5846.
- Lund, E. G., Guileyardo, J. M. & Russell, D. W. (1999). Proc. Natl Acad. Sci. USA, 96, 7238–7243.
- Lutjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Diczfalusy, U. & Bjorkhem, I. (1996). Proc. Natl Acad. Sci. USA, 93, 9799–9804.
- Ma, S. L., Tang, N. L., Lam, L. C. & Chiu, H. F. (2006). Int. Psychogeriatr.18, 37–45.
- McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J. (2005). Acta Cryst. D61, 458–464.
- McRee, D. E. (1999a). Practical Protein Crystallography, 2nd ed. San Diego: Academic Press.
- McRee, D. E. (1999b). J. Struct. Biol.125, 156–165.
- Mast, N., Andersson, U., Nakayama, K., Bjorkhem, I. & Pikuleva, I. A. (2004). Arch. Biochem. Biophys.428, 99–108.
- Matthews, B. W. (1962). J. Mol. Biol.33, 491–497.
- Merritt, E. & Bacon, D. (1997). Methods Enzymol.277, 505–524.
- Nagem, R. A. P., Dauter, Z. & Polikarpov, I. (2001). Acta Cryst. D57, 996–1002.
- Nagem, R. A., Polikarpov, I. & Dauter, Z. (2003). Methods Enzymol.374, 120–137.
- Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C. & Nebert, D. W. (1996). Pharmacogenetics, 6, 1–42.
- Omura, T. & Sato, R. (1964). J. Biol. Chem.239, 2370–2378.
- Otwinowski, Z. & Minor, W. (1997). Methods Enzymol.276, 307–326.
- Pflugrath, J. W. (1999). Acta Cryst. D55, 1718–1725.
- Pikuleva, I. A. (2006). Pharmacol. Ther.112, 761–773.
- Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D. & Johnson, E. F. (2007). J. Biol. Chem.282, 14348–14355.
- Schoch, G. A., Yano, J. K., Wester, M. R., Griffin, K. J., Stout, C. D. & Johnson, E. F. (2004). J. Biol. Chem.279, 9497–9503.
- Schwede, T., Kopp, J., Guex, N. & Peitsch, M. C. (2003). Nucleic Acids Res.31, 3381–3385.
- Scott, E. E., He, Y. A., Wester, M. R., White, M. A., Chin, C. C., Halpert, J. R., Johnson, E. F. & Stout, C. D. (2003). Proc. Natl Acad. Sci. USA, 100, 13196–13201.
- Scott, E. E., White, M. A., He, Y. A., Johnson, E. F., Stout, C. D. & Halpert, J. R. (2004). J. Biol. Chem.279, 27294–27301.
- Singh, R., White, M. A., Ramana, K. V., Petrash, J. M., Watowich, S. J., Bhatnagar, A. & Srivastava, S. K. (2006). Proteins, 64, 101–110.
- Strott, C. A. & Higashi, Y. (2003). J. Lipid Res.44, 1268–1278.
- Tedde, A., Rotondi, M., Cellini, E., Bagnoli, S., Muratore, L., Nacmias, B. & Sorbi, S. (2006). Neurobiol. Aging, 27, 773.e1–773.e3.
- Terwilliger, T. C. & Berendzen, J. (1999). Acta Cryst. D55, 849–861.
- Tickle, I. J., Laskowski, R. A. & Moss, D. S. (1998). Acta Cryst. D54, 243–252.
- Wang, F. & Jia, J. (2007). Brain Res.1147, 34–38.
- White, M. A., Liu, D., Holbrook, M. R., Shope, R. E., Barrett, A. D. T. & Fox, R. O. (2003). Acta Cryst. D59, 1049–1051.
- White, M. A., Watowich, S. J. & Fox, R. O. (1999). J. Appl. Cryst.32, 65–70.
- Yano, J. K., Wester, M. R., Schoch, G. A., Griffin, K. J., Stout, C. D. & Johnson, E. F. (2004). J. Biol. Chem.279, 38091–38094.
- Yogavel, M., Gill, J., Mishra, P. C. & Sharma, A. (2007). Acta Cryst. D63, 931–934.
- Zhao, Y., Sun, L., Muralidhara, B. K., Kumar, S., White, M. A., Stout, C. D. & Halpert, J. R. (2007). Biochemistry, 46, 11559–11567.
- Zhao, Y., White, M. A., Muralidhara, B. K., Sun, L., Halpert, J. R. & Stout, C. D. (2006). J. Biol. Chem.281, 5973–5981.
Source: PubMed